Sun Pharma Triumphs as Delhi HC Rejects Halt on Pruease Sales

The Delhi High Court has refused to stop Sun Pharma from selling its Pruease tablets, dismissing a trademark infringement plea by RSPL Health, the makers of Pro-ease sanitary products. RSPL argued that Sun Pharma’s “Pruease” was deceptively similar to their “Pro-ease” brand and could confuse consumers. However, the court found the products were entirely different—Pruease is a medicine for constipation, while Pro-ease is a line of sanitary napkins and related products.

 

Key points from the judgment:

The decision reinforces that not all similar-sounding trademarks create confusion, especially when the products are unrelated and marketed differently.

 

This outcome is a clear win for Sun Pharma, allowing Pruease tablets to remain on the shelves and setting a precedent for how courts may view trademark disputes involving unrelated product categories.

 

Sources: The Economic Times, Verdictum, LiveLaw